[go: up one dir, main page]

NO802030L - Fremgangsmaate til fremstilling av mavesyrenoeytriliserende midler, mavesyrenoeytraliserende midler og en fremgangsmaate for behandling av hypersurhet og sykdommer forbundet med dette - Google Patents

Fremgangsmaate til fremstilling av mavesyrenoeytriliserende midler, mavesyrenoeytraliserende midler og en fremgangsmaate for behandling av hypersurhet og sykdommer forbundet med dette

Info

Publication number
NO802030L
NO802030L NO802030A NO802030A NO802030L NO 802030 L NO802030 L NO 802030L NO 802030 A NO802030 A NO 802030A NO 802030 A NO802030 A NO 802030A NO 802030 L NO802030 L NO 802030L
Authority
NO
Norway
Prior art keywords
nutritizing
agents
procedure
magic acid
hypersurity
Prior art date
Application number
NO802030A
Other languages
English (en)
Other versions
NO152892C (no
NO152892B (no
Inventor
Eva Kristina Byroed
John Albert Sjoegren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NO802030L publication Critical patent/NO802030L/no
Publication of NO152892B publication Critical patent/NO152892B/no
Publication of NO152892C publication Critical patent/NO152892C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO802030A 1979-07-09 1980-07-04 Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon. NO152892C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7905972A SE7905972L (sv) 1979-07-09 1979-07-09 Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand

Publications (3)

Publication Number Publication Date
NO802030L true NO802030L (no) 1981-01-12
NO152892B NO152892B (no) 1985-09-02
NO152892C NO152892C (no) 1985-12-11

Family

ID=20338481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802030A NO152892C (no) 1979-07-09 1980-07-04 Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon.

Country Status (21)

Country Link
US (1) US4465667A (no)
EP (1) EP0022429B1 (no)
JP (1) JPS5618922A (no)
AR (1) AR228854A1 (no)
AT (1) ATE1968T1 (no)
AU (1) AU535403B2 (no)
CA (1) CA1146860A (no)
DE (1) DE3061333D1 (no)
DK (1) DK154265C (no)
ES (1) ES8106835A1 (no)
FI (1) FI71058C (no)
GR (1) GR69623B (no)
HK (1) HK43484A (no)
IE (1) IE50141B1 (no)
MY (1) MY8500445A (no)
NO (1) NO152892C (no)
NZ (1) NZ194165A (no)
PH (2) PH16372A (no)
PT (1) PT71503B (no)
SE (1) SE7905972L (no)
SG (1) SG9384G (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0642001B2 (ja) * 1983-10-20 1994-06-01 セイコーエプソン株式会社 合成樹脂製レンズ
JPS6486101A (en) * 1987-06-18 1989-03-30 Toray Industries Production of antireflecting article
JPH0696536B2 (ja) * 1988-02-26 1994-11-30 佐藤製薬株式会社 制酸剤含有内用懸濁液
US5158770A (en) * 1989-12-29 1992-10-27 Freund Industrial Co., Ltd. Aqueous solution containing ginkgo leaf extract
AU657882B2 (en) * 1993-03-26 1995-03-23 Wallace Victor Wind Improvements in or relating to the treatment of diarrhoea
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
SE509300C2 (sv) * 1995-02-02 1999-01-11 Sueddeutsche Kalkstickstoff Katjoniskt dispergerade aluminiumhydroxiduppslamningar
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US6187317B1 (en) 1999-07-14 2001-02-13 Judith Taylor Natural anti-diarrheal composition and method
DK1523984T3 (da) * 2003-10-13 2007-03-26 Zoser B Salama Farmaceutisk sammensætning indeholdende oxoplatin og dettes salte
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2211745A (en) * 1940-04-18 1940-08-13 Alba Pharmaceutical Company In Compound of aluminum hydroxide and process of making the same
US2999790A (en) * 1959-08-24 1961-09-12 Sterling Drug Inc Stable aluminum hydroxide suspension
US3239416A (en) * 1963-05-29 1966-03-08 Armour Pharma Aluminum hydroxide-metal hydroxide antacid and process of making the same
US3272704A (en) * 1963-06-06 1966-09-13 Armour Pharma Stable aluminum hydroxide-magnesium compound codried gel antacids and process of making the same
US3499963A (en) * 1964-04-15 1970-03-10 Armour Pharma Codried aluminum hydroxide-aluminum chelate antacid
US3350266A (en) * 1964-06-04 1967-10-31 Bristol Myers Co Antacid composition comprising aluminum hydroxide, magnesium hydroxide and magnesium gluconate
IL32020A (en) * 1968-04-18 1972-11-28 Brown G Antacid compositions
US3599150A (en) * 1969-08-01 1971-08-10 Miles Lab Stabilized aluminum hydroxide suspensions
GB1414121A (en) * 1971-09-15 1975-11-19 Smith W J Antacid composition and its preparation
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom

Also Published As

Publication number Publication date
FI802139A (fi) 1981-01-10
PH16372A (en) 1983-09-14
IE801402L (en) 1981-01-09
DE3061333D1 (en) 1983-01-20
JPS5618922A (en) 1981-02-23
IE50141B1 (en) 1986-02-19
JPS6411008B2 (no) 1989-02-23
EP0022429B1 (en) 1982-12-15
AU5973480A (en) 1981-01-15
ES493187A0 (es) 1981-09-01
SE7905972L (sv) 1981-01-10
NO152892C (no) 1985-12-11
GR69623B (no) 1982-07-06
FI71058C (fi) 1986-11-24
DK290080A (da) 1981-01-10
HK43484A (en) 1984-05-25
EP0022429A1 (en) 1981-01-14
FI71058B (fi) 1986-08-14
PT71503A (en) 1980-08-01
ATE1968T1 (de) 1982-12-15
AR228854A1 (es) 1983-04-29
DK154265C (da) 1989-03-28
PT71503B (en) 1981-12-11
AU535403B2 (en) 1984-03-22
ES8106835A1 (es) 1981-09-01
NZ194165A (en) 1984-07-06
MY8500445A (en) 1985-12-31
DK154265B (da) 1988-10-31
CA1146860A (en) 1983-05-24
PH16705A (en) 1984-01-20
SG9384G (en) 1985-02-15
NO152892B (no) 1985-09-02
US4465667A (en) 1984-08-14

Similar Documents

Publication Publication Date Title
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO148925C (no) Analogifremgangsmaate til fremstilling av 5-metyl-isoksazol-4-karboksylsyre-(4-trifluormetyl)-anilid med antiflogistisk og antireumatisk virkning
DK206079A (da) Herbicidt virksomme substituerede carboxyksyreamider og fremgangsmaade til deres fremstilling
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
DK445978A (da) Chromanderivater deres fremstilling og anvendelsesom insecticider og acaricider
NO151966C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO146394C (no) Analogifremgangsmaate til fremstilling av 1,2-difenyl-3-(imidazol-1-yl)-propan-2-oler med terapeutisk virkning
NO150879C (no) Fremgangsmaate for fremstilling av d-camforat av l-carnitinamid og d-camforat av d-carnitinamid
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO802030L (no) Fremgangsmaate til fremstilling av mavesyrenoeytriliserende midler, mavesyrenoeytraliserende midler og en fremgangsmaate for behandling av hypersurhet og sykdommer forbundet med dette
NO145236C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
DK395380A (da) Isocyanursyreforbindelser med cytostatisk virkning og fremgangsmaade til fremstilling heraf
NO780594L (no) Fremgangsmaate ved fremstilling av d,1-5-methyltetrahydrofolinsyre og dennes salter
TR20880A (tr) Akrilonitrilin aritilmasi
NO152007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7beta-(syn-2-oksyimino-arylacetamido)-3-(sulfoalkyltetrazol-5-yl-tiometyl)-cephem-4-karboksylsyrer
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
GB1553424A (en) Method of treating protozal diseases
DK489880A (da) Fremgangsmaade til behandling ff elmesyge
SE7704309L (sv) Bestralningsapparat for behandling av hudsjukdomar
NO145843C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme n1-glukofuranosid-6-yl-n3-nitroso-urinstoffer
NO802277L (no) Fremgangsmaate til fremstilling av terapeutisk aktive 25-halocholest-5-en-3beta,22-dioler og estere derav